
PlaqueTec
Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease.
About
PlaqueTec is a medtech company focused on developing and utilizing intracoronary liquid biopsy to identify the inflammatory drivers of cardiovascular disease (CVD). They are building a proprietary cardiovascular data lake called BioCarta, which is a repository of unique intracoronary proteomic and clinical data.
Key facts
At-a-glance profile data
- Website
- plaquetec.com
- Headquarters
- Cambridge, England, United Kingdom
- Total funding
- $5M (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 27 Apr 2026 | Funding Round | $5M | - |
Tech stack
Detected on plaquetec.com, last scanned 18 Sept 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has PlaqueTec raised?
PlaqueTec has raised a total of $5M in funding. The most recent round on record is Funding Round.
